AR and prostate carcinoma: Furthermore, the history of success in targeting nuclear receptors for cancer treatment (breast cancer, prostate cancer, acute promyelocytic leukemia) gives confidence that targeting AR for breast cancer therapy could be of tremendous importance in treating this disease, and indeed clinical trials are currently underway to test this hypothesis = [15].